HPLC Method for the Determination of Ketorolac in Human Plasma
- 1 March 1996
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 19 (6) , 957-967
- https://doi.org/10.1080/10826079608001926
Abstract
A precise and accurate HPLC method for the quantification of ketorolac in human plasma is described. Ketorolac and an added internal standard (a fluoro analog of ketorolac) are extracted from acidified plasma samples and the extract is further purified. The reconstituted sample is injected onto a reverse phase HPLC column. The method has a linear concentration range of 0.010-3.00 μg of ketorolac per aliquot of plasma, using 0.1 to 1.0 mL of plasma for analysis. The quantification limit of the method is 0.010 μg/mL. The intra- and inter-assay % CVs were less than 5.5%, and the mean recoveries ranged from 96% to 109%. The absolute recovery was 92%.Keywords
This publication has 6 references indexed in Scilit:
- Reversed-phase high-performance liquid chromatography of ketorolac and its application to bioequivalence studies in human serumJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Simultaneous determination of ketorolac and its hydroxylated metabolite in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Absolute configuration of (-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid, the active enantiomer of ketorolacJournal of Medicinal Chemistry, 1986
- Synthesis, antiinflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and related compoundsJournal of Medicinal Chemistry, 1985
- The analgesic and anti-inflammatory profile of (±)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS-37619)Inflammation Research, 1982
- BPPCDrugs of the Future, 1981